The primary objective is to advise on drug development with the most time and cost efficient program resulting in data standing regulatory and due diligence scrutiny.
Specialized Services
-
Drug Development strategy, planning and implementation
-
Definition and fine tuning of regulatory strategies, including meetings with Regulatory Agencies
-
Development of Proof-of-Concept studies
-
Advise on selection of clinical investigators and CROs
-
Consultancy on Drug Safety Management , including Risk Management.
-
Support for meetings with potential licensees and/or investors